Pharmacogénétique de l’infliximab dans la maladie de Crohn (original) (raw)
The duration of effect of infliximab maintenance treatment in paediatric Crohn’s disease is limited
Lissy Ridder
Alimentary Pharmacology & Therapeutics, 2010
View PDFchevron_right
Biologic Therapies for Inflammatory Bowel Diseases
Vassilis Valatas
2013
View PDFchevron_right
Review of the safety with biologics in inflammatory bowel disease
Santiago García-lópez
Journal of IMIDs
View PDFchevron_right
When to use biological agents in inflammatory bowel disease
Rupert Leong
Journal of Gastroenterology and Hepatology, 2012
View PDFchevron_right
Favorable response to subcutaneous administration of infliximab in rats with experimental colitis
John Triantafillidis
World Journal of Gastroenterology, 2005
View PDFchevron_right
Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
Andrew Macpherson
Pharmaceuticals, 2010
View PDFchevron_right
Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study)
Ahmed Shelbaya
Advances in Therapy
View PDFchevron_right
Infliximab Therapy in 30 Patients With Refractory Pediatric Crohn Disease With and Without Fistulas in The Netherlands
Lissy Ridder
Journal of Pediatric Gastroenterology and Nutrition, 2004
View PDFchevron_right
Infliximab With Low-Dose Methotrexate for Prevention of Postsurgical Recurrence of Ileocolonic Crohn Disease
Giovanni Terrosu
Archives of Internal Medicine, 2007
View PDFchevron_right
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease
guy lambrecht
Clinical Gastroenterology and Hepatology, 2020
View PDFchevron_right
692 Impact of Body Mass Index on Efficacy of Infliximab in Children With Inflammatory Bowel Disease
Shehzad Saeed
Gastroenterology, 2013
View PDFchevron_right
Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn’s Disease in Children
Eytan Wine
Inflammatory Bowel Diseases
View PDFchevron_right
Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease
Klaus Bendtzen
Alimentary Pharmacology & Therapeutics, 2011
View PDFchevron_right
Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
Stephen Middleton
Gastroenterology, 2014
View PDFchevron_right
Infliximab and the risk of latent viruses reactivation in active Crohnʼs disease
Massimiliano Bergallo
Inflammatory Bowel Diseases, 2007
View PDFchevron_right
Inflammatory Bowel Disease. From Bench to Bedside
Fergus Shanahan
Digestive and Liver Disease, 2004
View PDFchevron_right
Infliximab in pediatric ulcerative colitis: Two year follow up
Robert Baldassano
Gastroenterology, 2003
View PDFchevron_right
Comparison of original and biosimilar infliximab (CTP-13) in biologic-na�ve patients with Crohn�s disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain
Keyla Villa
Revista Española de Enfermedades Digestivas, 2020
View PDFchevron_right
Anti-inflammatory Disease Therapies: Challenges and Strategies in Drug Development
Joel Parry
Toxicologic Pathology, 2012
View PDFchevron_right
İnflamatuar Bağirsak Hastalarinda Serum Resolvi̇n D1 Ve E1 Düzeyleri̇ni̇n Değerlendi̇ri̇lmesi̇
İrfan KÜÇÜK
DergiPark (Istanbul University), 2023
View PDFchevron_right
Kronik Bronşitli Farelerde Teofilin ve Resveratrolün Anti-İnflamatuar Etkinliklerinin Karşılaştırılması
Fusun Yildiz
Turkiye Klinikleri Journal of Medical Sciences, 2011
View PDFchevron_right
Evaluation of Infliximab Effects on Gastrointestinal Bleeding in Crohn’s Disease Using Double-Balloon Endoscopy
Toshimi Chiba
Case Reports in Gastroenterology, 2009
View PDFchevron_right
Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future
Saurabh dawra
Future pharmacology, 2024
View PDFchevron_right
Infliximab‐induced autoimmune hepatitis requiring liver transplantation
Karim Qumosani
Clinical Case Reports, 2019
View PDFchevron_right
Infliximab induced chilblain lupus in a patient with rheumatoid arthritis
thierry schaeverbeke
The Journal of rheumatology, 2005
View PDFchevron_right